Use your antibodies-online credentials, if available.
The protein encoded by S10A1 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. 再加上，我们可以发s100-a1 蛋白 (1)和数多这个蛋白质的别的产品。
Showing 3 out of 3 products:
The results indicate that changes in the circulating level of S100A1 (显示 S100A1 抗体) protein occur in metabolic syndrome patients. The strong correlation between serum zinc-alpha2-glycoprotein and S100A1 (显示 S100A1 抗体) might suggest that production or release of these two proteins could be related mechanistically.
The results indicated that S100A1 (显示 S100A1 抗体) enhanced the ovarian cancer cell proliferation and migration.
found that S100B (显示 S100B 抗体) plays a crucial role in blocking the interaction site between RAGE (显示 AGER 抗体) V domain and S100A1 (显示 S100A1 抗体). A cell proliferation assay WST (显示 EEF1A2 抗体)-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment
Study provides evidence that mir-363 and its target S100A1 are under the regulatory function of FOXD2-AS1 aggravating nasopharyngeal carcinoma carcinogenesis.
X-ray crystal structure of human calcium-bound S100A1 (显示 S100A1 抗体) has been reported.
a molecular mechanism for the potential regulation of TRPM1 (显示 TRPM1 抗体) by S100A1 (显示 S100A1 抗体)
Data suggest that calcium signaling plays important role in prevention of protein misfolding; complexes of S100A1 (显示 S100A1 抗体) and STIP1 (显示 STIP1 抗体) are key players in this pathway; the stoichiometry of S100A1 (显示 S100A1 抗体)/STIP1 (显示 STIP1 抗体) interaction appears to be three S100A1 (显示 S100A1 抗体) dimers plus one STIP1 (显示 STIP1 抗体) monomer; each S100A1 (显示 S100A1 抗体)-STIP1 (显示 STIP1 抗体)-binding interaction is entropically driven. (S100A1 (显示 S100A1 抗体) = S100 calcium binding protein A1 (显示 S100A1 抗体); STIP1 (显示 STIP1 抗体) = stress-induced-phosphoprotein 1 (显示 STIP1 抗体)) [REVIEW]
Data suggest that three dimers of S100A1 (S100 calcium binding protein A1 (显示 S100A1 抗体)) associate with one molecule of STIP1 (显示 STIP1 抗体) (stress-inducible phosphoprotein 1) in a calcium-dependent manner; individual STIP1 (显示 STIP1 抗体) TPR (tetratricopeptide repeat) domains, TPR1, TPR2A and TPR2B, bind a single S100A1 (显示 S100A1 抗体) dimer with significantly different affinities; TPR2B domain possesses highest affinity for S100A1 (显示 S100A1 抗体).
Results identified amino acids motif in S100A1 (显示 S100A1 抗体) for protein binding to 2-oxohistidine which appears to be an evolutionarily conserved capacity from bacteria to human.
a correlation between S100B (显示 S100B 抗体) + A1-positive Human Articular Chondrocytes in monolayer culture and their neochondrogenesis capacity in pellet culture, is reported.
identified S100A1 (显示 S100A1 抗体), but not calmodulin (显示 KRIT1 抗体) or other S100 proteins, as a potent molecular chaperone (显示 HSP90AA1 抗体) and a new member of the Hsp70 (显示 HSP70 抗体)/Hsp90 (显示 HSP90 抗体) multichaperone complex (S100A1 (显示 S100A1 抗体))
Results suggest that S100A1 (显示 S100A1 抗体) can act as a linker between the calcium and redox signalling pathways.
beta-mercaptoethanol modification of apo (显示 C9orf3 抗体)-S100A1 (显示 S100A1 抗体) makes its structure more similar to that of holo-S100A1 (显示 S100A1 抗体), so that it becomes much better adjusted for calcium coordination.
Data (including data from studies using knockout mice) suggest that S100A1 (显示 S100A1 抗体) (S-100 calcium-binding protein (显示 GUCA1B 抗体) A1 (显示 BCL2A1 抗体), alpha chain (显示 FCGRT 抗体)) is involved in protein kinase A- (RIIalpha and RIIbeta (显示 PRKAR2B 抗体))-dependent signaling resulting in nuclear redistribution/influx of HDAC4 (histone deacetylase 4 (显示 HDAC5 抗体)) in skeletal muscle fibers.
S100A1 (显示 S100A1 抗体)-KO exhibited increased right ventricular (RV) weight and elevated RV pressure in the absence of altered left ventricular filling pressures, increase in wall thickness of muscularized pulmonary arteries and a reduction in microvascular perfusion.
S100A1 (显示 S100A1 抗体) and S100B (显示 S100B 抗体) are dispensable for endochondral ossification during skeletal development.
S100A1 ablationalso reduced plaque associated and increased non-plaque associated PO4-Akt and PO4-GSK3beta staining.
Patients with acute myocardial infarction (MI) showed significantly increased S100A1 (显示 S100A1 抗体) serum levels. Experimental MI in mice induced comparable S100A1 (显示 S100A1 抗体) release. S100A1 (显示 S100A1 抗体) signaling in cardiac fibroblasts occurs through endosomal TLR4 (显示 TLR4 抗体)/MyD88 (显示 MYD88 抗体).
hypoxia-induced MiR (显示 MLXIP 抗体)-138 is an essential mediator of EC dysfunction via its ability to target the 3'UTR (显示 UTS2R 抗体) of S100A1 (显示 S100A1 抗体).
Report downregulation of S100A1 (显示 S100A1 抗体) expression in critical limb ischemia impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase (显示 NOS 抗体) regulation.
S100A1 (显示 S100A1 抗体) and calmodulin bind to an overlapping domain on the ryanodine receptor (显示 RYR3 抗体) type 1 to tune the Ca2 (显示 CA2 抗体)+ release process, and thereby regulate skeletal muscle function. (Review)
The RyR1 (显示 RYR1 抗体)-L3625D mutation removed both an early activating effect of S100A1 (显示 S100A1 抗体) and calmodulin and delayed the suppression of RyR1 (显示 RYR1 抗体) Ca2 (显示 CA2 抗体)+ release, providing new insights into calmodulin and S100A1 (显示 S100A1 抗体) regulation of skeletal muscle excitation-contraction coupling.
Data suggest that the absence of S100A1 (显示 S100A1 抗体) suppresses physiological AP-induced Ca(2 (显示 CA2 抗体)+) release flux, resulting in impaired contractile activation and force production in skeletal muscle.
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-induced Ca2+ release, inhibition of microtubule assembly, and inhibition of protein kinase C-mediated phosphorylation. Reduced expression of this protein has been implicated in cardiomyopathies.
S-100 protein alpha chain
, S-100 protein subunit alpha
, S100 alpha
, S100 calcium-binding protein A1
, S100 protein, alpha polypeptide
, protein S100-A1